Short-term continuous infusion of mitozantrone for advanced breast cancer

[1]  N. Mulder,et al.  A phase I pharmacokinetic study of 21-day continuous infusion mitoxantrone. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.